Patient characteristics of new initiators of glycopyrronium bromide (GLY) - A multinational, multi-database real-world drug-utilization study

Conclusion: In real life, majority of first-time GLY use was in line with product label regarding dosing and COPD severity. More than 1/4 of patients used long-acting bronchodilators before GLY start. Cardiovascular comorbidity was considerable.

Source: European Respiratory Journal - November 7, 2016 Category: Respiratory Medicine Authors: Verhamme, K. M. C., De Ridder, M., Pedersen, L., Prieto-Alhambra, D., Lapi, F., Rijnbeek, P., Amar, R. K., Sturkenboom, M. Tags: 5.1 Airway Pharmacology and Treatment Source Type: research